glp-1 once weekly injection The risk of hair loss in patients taking drugs for obesity or diabetes, while low, is higher than with other diabetes drugs, new studies suggest. More details at the 🔗 in What are GLP-1 drugs? The

The findings obtained from the SMART collaborative meta-analysis (SGLT2 Inhibitor Meta-Analysis Cardio-Renal Trialists), designed to evaluate the impact of SGLT2is on cardiovascular and renal outcomes based on the concomitant use or non-use of GLP1-RAs, included 12 controlled clinical trials with 73,238 participants, of whom 3065 (4.2%) received GLP1-RAs

No loading phase is needed, and there's no evidence that tapering on or off changes outcomes

Nomura, S

This GLP-1 medicationbest known by the brand names Ozempic, Wegovy, and Rybelsushas helped many people lose weight and improve metabolic health, including blood sugar control and cardiovascular risk